Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rochester Medical Corporation (ROCM) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rochester Medical Corporation. Table 2 shows the detailed insider transactions. This company's CIK number is 868368.
Total stock buying since 2010: $68,499.
Total stock sales since 2010: $3,283,013.
Total stock option exercises since 2010: $1,230,454.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2013 | 0 | $0 | 45,500 | $593,278 | 45,500 | $211,917 |
| 2012 | 4,600 | $42,839 | 76,000 | $775,067 | 90,000 | $400,377 |
| 2011 | 3,500 | $25,660 | 131,700 | $1,350,710 | 182,000 | $420,198 |
| 2010 | 0 | $0 | 52,000 | $563,958 | 82,000 | $197,962 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2013-03 | 0 | $0 | 19,000 | $280,050 | 19,000 | $88,430 |
| 2013-02 | 0 | $0 | 26,500 | $313,228 | 26,500 | $123,487 |
| 2012-12 | 500 | $4,950 | 46,000 | $483,887 | 90,000 | $400,377 |
| 2012-11 | 2,100 | $21,949 | 0 | $0 | 0 | $0 |
| 2012-03 | 0 | $0 | 30,000 | $291,180 | 0 | $0 |
| 2012-01 | 2,000 | $15,940 | 0 | $0 | 0 | $0 |
| 2011-12 | 1,500 | $10,410 | 0 | $0 | 0 | $0 |
| 2011-11 | 2,000 | $15,250 | 0 | $0 | 0 | $0 |
| 2011-10 | 0 | $0 | 0 | $0 | 12,000 | $25,980 |
| 2011-09 | 0 | $0 | 20,000 | $157,504 | 40,000 | $86,600 |
| 2011-07 | 0 | $0 | 0 | $0 | 8,000 | $17,320 |
| 2011-03 | 0 | $0 | 10,000 | $100,000 | 10,000 | $27,500 |
| 2011-02 | 0 | $0 | 101,700 | $1,093,206 | 112,000 | $262,798 |
| 2010-11 | 0 | $0 | 44,000 | $493,110 | 44,000 | $114,260 |
| 2010-10 | 0 | $0 | 0 | $0 | 30,000 | $64,950 |
| 2010-09 | 0 | $0 | 8,000 | $70,848 | 8,000 | $18,752 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-03-01 | Anglin Robert M (VP Quality & Regulatory) | Sale | 4,000 | 14.70 | 58,800 |
| 2013-03-01 | Anglin Robert M (VP Quality & Regulatory) | Option Ex | 4,000 | 4.62 | 18,500 |
| 2013-03-01 | Sholtis Martyn R (Corporate Vice President) | Sale | 15,000 | 14.75 | 221,250 |
| 2013-03-01 | Sholtis Martyn R (Corporate Vice President) | Option Ex | 15,000 | 4.66 | 69,930 |
| 2013-02-28 | Sholtis Martyn R (Corporate Vice President) | Sale | 1,500 | 14.80 | 22,203 |
| 2013-02-28 | Sholtis Martyn R (Corporate Vice President) | Option Ex | 1,500 | 4.62 | 6,937 |
| 2013-02-01 | Conway Philip J (Vice President) | Sale | 25,000 | 11.64 | 291,025 |
| 2013-02-01 | Conway Philip J (Vice President) | Option Ex | 25,000 | 4.66 | 116,550 |
| 2012-12-26 | Smith Benson (Director) | Option Ex | 44,000 | 4.79 | 210,628 |
| 2012-12-12 | Grinde Sarah L. (VP, Development and Research) | Buy | 500 | 9.90 | 4,950 |
| 2012-12-12 | Conway Anthony J (President and Secretary) | Sale | 16,000 | 9.90 | 158,400 |
| 2012-12-12 | Conway Anthony J (President and Secretary) | Option Ex | 16,000 | 4.12 | 66,000 |
| 2012-12-04 | Sholtis Martyn R (Corporate Vice President) | Sale | 9,700 | 10.91 | 105,827 |
| 2012-12-04 | Sholtis Martyn R (Corporate Vice President) | Option Ex | 9,700 | 4.12 | 40,012 |
| 2012-12-04 | Jonas David A (CFO and Treasurer) | Sale | 10,000 | 10.81 | 108,100 |
| 2012-12-04 | Jonas David A (CFO and Treasurer) | Option Ex | 10,000 | 4.12 | 41,250 |
| 2012-12-03 | Sholtis Martyn R (Corporate Vice President) | Sale | 300 | 11.00 | 3,300 |
| 2012-12-03 | Sholtis Martyn R (Corporate Vice President) | Option Ex | 300 | 4.12 | 1,237 |
| 2012-12-03 | Conway Philip J (Vice President) | Sale | 10,000 | 10.83 | 108,260 |
| 2012-12-03 | Conway Philip J (Vice President) | Option Ex | 10,000 | 4.12 | 41,250 |
| 2012-11-26 | Shepard Peter (Director) | Buy | 37 | 11.00 | 407 |
| 2012-11-23 | Shepard Peter (Director) | Buy | 501 | 10.85 | 5,435 |
| 2012-11-21 | Shepard Peter (Director) | Buy | 500 | 10.44 | 5,220 |
| 2012-11-20 | Shepard Peter (Director) | Buy | 662 | 10.35 | 6,851 |
| 2012-11-16 | Shepard Peter (Director) | Buy | 400 | 10.09 | 4,036 |
| 2012-03-12 | Conway Anthony J (President and Secretary) | Sale | 30,000 | 9.71 | 291,180 |
| 2012-01-27 | Shepard Peter (Director) | Buy | 2,000 | 7.97 | 15,940 |
| 2011-12-09 | Sholtis Martyn R (Corporate Vice President) | Buy | 1,500 | 6.94 | 10,410 |
| 2011-11-21 | Boehm Darnell L (Director) | Buy | 2,000 | 7.62 | 15,250 |
| 2011-10-12 | Smith Benson (Director) | Option Ex | 12,000 | 2.17 | 25,980 |
| 2011-09-09 | Conway Philip J (Vice President) | Sale | 17,200 | 7.85 | 135,020 |
| 2011-09-09 | Conway Philip J (Vice President) | Option Ex | 17,200 | 2.17 | 37,238 |
| 2011-09-08 | Jonas David A (CFO and Treasurer) | Option Ex | 20,000 | 2.17 | 43,300 |
| 2011-09-08 | Conway Philip J (Vice President) | Sale | 2,800 | 8.03 | 22,484 |
| 2011-09-08 | Conway Philip J (Vice President) | Option Ex | 2,800 | 2.17 | 6,062 |
| 2011-07-01 | Anglin Robert M (VP Quality & Regulatory) | Option Ex | 8,000 | 2.17 | 17,320 |
| 2011-03-17 | Smith Benson (Director) | Sale | 10,000 | 10.00 | 100,000 |
| 2011-03-17 | Smith Benson (Director) | Option Ex | 10,000 | 2.75 | 27,500 |
| 2011-02-28 | Conway Philip J (Vice President) | Sale | 7,065 | 10.56 | 74,578 |
| 2011-02-28 | Conway Philip J (Vice President) | Option Ex | 7,065 | 2.34 | 16,560 |
| 2011-02-22 | Conway Philip J (Vice President) | Sale | 12,935 | 10.32 | 133,553 |
| 2011-02-22 | Conway Philip J (Vice President) | Option Ex | 12,935 | 2.34 | 30,319 |
| 2011-02-22 | Conway Anthony J (President and Secretary) | Option Ex | 8,300 | 2.34 | 19,455 |
| 2011-02-18 | Conway Anthony J (President and Secretary) | Sale | 7,700 | 10.71 | 82,467 |
| 2011-02-18 | Conway Anthony J (President and Secretary) | Option Ex | 7,700 | 2.34 | 18,048 |
| 2011-02-17 | Conway Anthony J (President and Secretary) | Sale | 34,000 | 10.75 | 365,568 |
| 2011-02-17 | Conway Anthony J (President and Secretary) | Option Ex | 34,000 | 2.35 | 79,968 |
| 2011-02-16 | Jonas David A (CFO and Treasurer) | Sale | 40,000 | 10.93 | 437,040 |
| 2011-02-16 | Jonas David A (CFO and Treasurer) | Option Ex | 40,000 | 2.34 | 93,760 |
| 2011-02-07 | Anglin Robert M (VP Quality & Regulatory) | Option Ex | 2,000 | 2.34 | 4,688 |
| 2010-11-10 | Conway Philip J (Vice President) | Sale | 16,090 | 11.18 | 179,886 |
| 2010-11-09 | Conway Philip J (Vice President) | Sale | 7,910 | 11.28 | 89,224 |
| 2010-11-09 | Conway Philip J (Vice President) | Option Ex | 24,000 | 2.62 | 63,000 |
| 2010-11-08 | Jonas David A (CFO and Treasurer) | Sale | 20,000 | 11.20 | 224,000 |
| 2010-11-08 | Jonas David A (CFO and Treasurer) | Option Ex | 20,000 | 2.56 | 51,260 |
| 2010-10-07 | Conway Anthony J (President and Secretary) | Option Ex | 30,000 | 2.17 | 64,950 |
| 2010-09-07 | Anglin Robert M (VP Quality & Regulatory) | Sale | 8,000 | 8.86 | 70,848 |
| 2010-09-07 | Anglin Robert M (VP Quality & Regulatory) | Option Ex | 8,000 | 2.34 | 18,752 |
Insider trading activities including stock purchases, stock sales, and option exercises of ROCM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rochester Medical Corporation (symbol ROCM, CIK number 868368) see the Securities and Exchange Commission (SEC) website.